{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:07:12Z","timestamp":1759018032705,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ophtha.2008.12.021","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T04:45:36Z","timestamp":1241412336000},"page":"990-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Angiotensin II Type 1 Receptor Expression in Temporal Arteries from Patients with Giant Cell Arteritis"],"prefix":"10.1016","volume":"116","author":[{"given":"Ivan","family":"Dimitrijevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Malmsj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pehr","family":"Rissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.ophtha.2008.12.021_bib1","first-page":"S6","article-title":"Clinical features of GCA\/PMR","volume":"18","author":"Hunder","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9394(14)70136-9","article-title":"Giant cell arteritis: new concepts in pathogenesis and implications for management","volume":"123","author":"Weyand","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jcp.53.2.137","article-title":"The importance of skip lesions in temporal arteritis","volume":"53","author":"Poller","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.57.6.380","article-title":"Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis","volume":"57","author":"Rauzy","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2008.12.021_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-9071.2006.01186.x","article-title":"Giant cell arteritis","volume":"34","author":"Carroll","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.12.021_bib7","first-page":"S29","article-title":"The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis","volume":"21","author":"Nuenninghoff","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","article-title":"Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms","volume":"86","author":"Ruiz-Ortega","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ophtha.2008.12.021_bib9","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1046\/j.1523-1755.64.s86.12.x","article-title":"Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy","author":"Mezzano","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ophtha.2008.12.021_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.RES.86.12.1187","article-title":"Cytokine actions of angiotensin II","volume":"86","author":"Sadoshima","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ophtha.2008.12.021_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9343(01)01001-4","article-title":"Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease","volume":"112","author":"Halkin","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2008.12.021_bib12","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.CIR.0000121735.52471.AC","article-title":"Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity","volume":"109","author":"Cipollone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2008.12.021_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2008.12.021_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.021_bib15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1006\/bbrc.1994.1613","article-title":"Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor","volume":"200","author":"Tsuzuki","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ophtha.2008.12.021_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-291X(92)91600-U","article-title":"Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor","volume":"183","author":"Furuta","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ophtha.2008.12.021_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ophtha.2008.12.021_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00001573-200007000-00010","article-title":"Fibrosis and hypertensive heart disease","volume":"15","author":"Weber","year":"2000","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1172\/JCI118807","article-title":"Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure","volume":"98","author":"Levy","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ophtha.2008.12.021_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.69.1.107","article-title":"Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries","volume":"69","author":"Brilla","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ophtha.2008.12.021_bib21","first-page":"H610","article-title":"Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells","volume":"259","author":"Baker","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ophtha.2008.12.021_bib22","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/00004872-199816121-00026","article-title":"Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors","volume":"16","author":"Zhuo","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.ophtha.2008.12.021_bib23","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1161\/01.CIR.94.11.2756","article-title":"Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease","volume":"94","author":"Diet","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2008.12.021_bib24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2008.12.021_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/oxfordjournals.jbchem.a132183","article-title":"Binding sites for angiotensin II in human mononuclear leucocytes","volume":"84","author":"Shimada","year":"1978","journal-title":"J Biochem"},{"key":"10.1016\/j.ophtha.2008.12.021_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1507\/endocrj.42.15","article-title":"Modulation of angiotensin II type 1 receptor mRNA expression in human blood cells: comparison of platelets and mononuclear leucocytes","volume":"42","author":"Suzuki","year":"1995","journal-title":"Endocr J"},{"key":"10.1016\/j.ophtha.2008.12.021_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2006.01.007","article-title":"Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study","volume":"134","author":"Rasini","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.ophtha.2008.12.021_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0014-5793(94)00531-1","article-title":"Activation of human peripheral monocytes by angiotensin II","volume":"347","author":"Hahn","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ophtha.2008.12.021_bib29","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","volume":"82","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int Suppl"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200801275X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200801275X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:39Z","timestamp":1758981459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200801275X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S016164200801275X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.021","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Angiotensin II Type 1 Receptor Expression in Temporal Arteries from Patients with Giant Cell Arteritis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}